Medical Device Developments’ Post

Reviewing Endovascular and Conventional Angioplasty: Challenges in Modern Patient-Centered Care https://lnkd.in/et3ezgRK

💡 GI endoscopy is unique among diagnostic and screening procedures in enabling clinicians, upon encountering suspicious polyps, to effectively treat some before sending patients home. 🩺 But the ability of most endoscopists to remove, at the time of diagnosis, all premalignant cases, is limited by the fragility of the environment in which they’re working, the size of the polyp and the high level of skills required to resect tissue endoscopically in the gastrointestinal tract. 💊 With a novel application of pulsed field ablation, Mirai Medical enables clinicians with GI endoscopy skills to safely treat the disease they find during screening and diagnostic procedures: https://bit.ly/3VjbFgQ #medtech #medicaldevices #medtechinnovation #medtechindustry

Zeineddine et al. from the productive Phoenix group analyzed the outcomes in a group of patients with pectus excavatum who had very high Haller indices and underwent minimally invasive surgical repair. Excellent study. Does a high Haller index influence outcomes in pectus excavatum repair? Zeineddine RM, Botros M, Shawwaf KA, Moosavi R, Aly MR, Farina JM, Lackey JJ, Sandstrom BA, Jaroszewski DE. J Thorac Cardiovasc Surg. 2024 Apr 10:S0022-5223(24)00292-7. doi: 10.1016/j.jtcvs.2024.04.005. I was struck by the rate of sternal and rib fractures in these cases. I wrote a Letter to the Editor commenting on: a) dissecting the retrosternal tunnel from left to right; c) abandoning the use of the thoracic introducer (or dissector); d) lateralizing the hinge points. You can find my comments here: https://lnkd.in/dekPRmPU The authors counter-argued. You can find their comments here: https://lnkd.in/dV4BXFAX With this, I believe that, together, we have ended up highlighting several relevant technical aspects of the surgical treatment of pectus. If you are interested in MIRPE, it may be worth checking out these publications.

Understanding the VS Classification for Endoscopic Characterization Did you know that endoscopic characterization plays a crucial role in gastrointestinal diagnostics? 🌍🔬 The VS (Vessel plus Surface) classification, also known as the Yao classification, is a framework introduced by Yao that assesses both the mucosal surface and the vessels. 🩺🔍 Key aspects of the VS classification include regular and irregular vessels, as well as regular and irregular surfaces. By incorporating this classification into endoscopy reports, we can enhance diagnostic precision. 💡✨ One vital indicator in this process is the demarcation line, which marks the boundary between cancerous and non-cancerous tissues. 📏💢 Join us as we delve deeper into the VS classification and explore the significance of the demarcation line in diagnosing and understanding gastrointestinal abnormalities. Stay tuned for more insights! 🤓🔬

The superior mesenteric artery can be windowed and (/or) stented, followed by delayed aortic repair. Priority should be given to revascularization of the superior mesenteric artery, followed by central aortic repair. During central aortic repair, direct blood perfusion should be performed on the distal true lumen of the superior mesenteric artery, leading to resulting in favorable therapeutic outcomes. The research results indicate that even after surgical aortic repair, intestinal ischemic necrosis may still occur. In such cases, prompt laparotomy and necessary necrotic bowel resection are crucial for saving the patient's life.

An article published in the Journal of Radiology explored the critical topic of radiation safety in interventional radiology procedures. The increasing frequency of these procedures, coupled with a reevaluation of radiation risks, has emphasized the need for effective safety measures. The article highlights ICRP's stricter dose limits and patient DRLs, improved regulations and training for staff protection, and technological progress with standardized dose reporting and optimized imaging protocols to minimize patient exposure. Minimize scatter radiation exposure for yourself and your team by up to 95% with RADPAD® Shields! Clinically proven by over 40 studies, our disposable shields are uniquely effective at reducing high levels of scatter radiation. Prioritize safety and efficiency by minimizing both staff and patient exposure. Choose RADPAD®! #radiationprotection #interventionalradiology #interventionalcardiology #RADPAD #healthcare

The training for and practice of percutaneous transluminal coronary angioplasty: results of two surveys https://t.co/GJ84TKYPSc #EurekaMag

Evasc Neurovascular Expands European Presence: Milestone Achievement with Eclips Device and Launch of German Subsidiary Evasc Neurovascular, a leading medical technology company specializing in endovascular repair solutions for cerebral aneurysms, proudly announces its strategic growth initiatives. The company has achieved a milestone of 120 successful cases with its innovative Eclips device and is expanding its European operations with the establishment of a new subsidiary, Evasc Neurovascular GmbH, headquartered in Germany. This expansion signifies a significant leap forward in Evasc's commitment to providing enhanced neurovascular care solutions in Europe. By establishing a direct presence in Germany, Evasc aims to facilitate more efficient services and direct sales, solidifying its position as a key player in the European market. In parallel with this expansion, Evasc reports noteworthy progress in the France EESIS trial, a crucial component of the company's ongoing efforts to validate the efficacy and safety of its groundbreaking neurovascular treatments. The strategic move into Germany positions Evasc to contribute even more significantly to the advancement of neurovascular care throughout Europe. Evasc's success extends beyond geographical boundaries, with increasing recognition and adoption within the NeuroInterventional Radiology (NIR) community. Its cutting-edge solutions have demonstrated remarkable promise, particularly in the treatment of wide neck bifurcation aneurysms—an area that has historically presented challenges within neurovascular care. In the current year alone, Evasc has successfully treated 80 patients, achieving a commendable milestone in the company's history. This accomplishment underscores Evasc's unwavering dedication to improving patient outcomes and advancing neurovascular care. As part of Evasc Neurovascular's commitment to advancing patient care, the establishment of Evasc Neurovascular GmbH in Germany underscores the company's dedication to localizing support and resources for its European clientele. The move aims to foster stronger relationships with healthcare professionals and institutions, ensuring timely access to Evasc's innovative neurovascular solutions. This strategic expansion aligns with the company's vision of making a meaningful impact on the global landscape of cerebral aneurysm treatment, reinforcing Evasc Neurovascular's position as a trusted partner in the pursuit of better care and improved outcomes. "Our expansion into Germany and our ongoing success in clinical trials and patient treatments are demonstrations of the Evasc dedication to excellence and paving new ground in the world of neurovascular health,” commented a spokesperson from Evasc Neurovascular. “This positive momentum will only continue. We are confident our company will continue to be instrumental in shaping the landscape of neurovascular care worldwide."

Cardiac Resynchronization Therapy (#CRT) procedures can be long-lasting and expose operators to radiation. But did you know that the use of RADPAD® Radiation Protection Shields can significantly reduce the equivalent dose at the operator’s hand? This article discusses the quantifiable reduction in radiation exposure achieved by using RADPAD® during CRT procedures. It’s another testament to the effectiveness of RADPAD®, backed by our 40 clinical studies. At RADPAD® Radiation Protection, we’re dedicated to reducing radiation exposure for healthcare professionals. Let’s continue to prioritize safety in all medical procedures! Read more about the study here: https://lnkd.in/graa4msJ #RADPAD #RadiationProtection #RadiationSafety #Cardiology #MedEd #meddevice

RADPAD Reduces Radiation by More Than 68% During Complex PCI Procedures! A study published in the American Journal of Cardiology investigated the effectiveness of RADPAD® Radiation Protection Shields in minimizing radiation exposure for interventional cardiologists performing complex PCI procedures. The study focused on 60 patients undergoing complex PCI, including procedures with: - Rotational atherectomy - Multivessel PCI - Chronic total occlusions (CTOs) RADPAD® significantly reduced radiation exposure to operators compared to the control group, especially when considering radiation dose relative to procedure duration. The study found a significant difference in the rate of radiation dose increase between the groups: RADPAD Group: Slope = 1.44 No RADPAD Group: Slope = 4.60 This translates to a slower increase in radiation dose per minute of fluoroscopy for operators using RADPAD®. Choose RADPAD®, backed by more than 40 clinical studies, for a safer work environment and continued dedication to patient care. #RADPAD #RadiationProtection #Cardiology #PCI #MedEd #HealthcareSafety